Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marsam v. Geneva

Executive Summary

Discussions "to resolve matters in dispute" between the two generic manufacturers are under way, the firms reported Aug. 25. A joint press release states that the two companies have agreed to "take no further steps" in the ongoing litigation pending the outcome of the talks. Marsam is charging Geneva, in a suit filed on July 22, with violating the terms of a joint venture agreement between the firms. Marsam's suit seeks, among other things, the dissolution of the joint venture agreement and $5 mil. in punitive damages ("The Pink Sheet" July 27, T&G-1).

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel